Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Mark T OstermanJames D Lewis

Abstract

The benefit of continuing immunomodulators when "stepping up" to anti-tumor necrosis factor (anti-TNF) therapy for Crohn's disease (CD) is uncertain. This study assessed the effectiveness and safety of immunomodulators with anti-TNF therapy in CD. We conducted a retrospective cohort study of new users of anti-TNF therapy for CD in Medicare. Users of anti-TNF combination therapy with immunomodulators were matched to up to 3 users of anti-TNF monotherapy via propensity score and compared by using 3 metrics of effectiveness-surgery, hospitalization, and discontinuation of anti-TNF therapy or surgery-and 2 metrics of safety-serious infection and non-Candida opportunistic infection. Cox regression was used for all analyses. Among new users of infliximab, we matched 381 users of combination therapy to 912 users of monotherapy; among new users of adalimumab, we matched 196 users of combination therapy to 505 users of monotherapy. Combination therapy occurred predominantly as "step up" after thiopurine therapy. The rates of surgery (hazard ratio [HR], 1.20; 95% confidence interval, 0.73-1.96), hospitalization (HR, 0.82; 0.57-1.19), discontinuation of anti-TNF therapy or surgery (HR, 1.09; 0.88-1.34), and serious infection (HR, 0.93; 0....Continue Reading

References

Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Sep 13, 2003·Health Services Research·Sebastian SchneeweissRobert J Glynn
Nov 5, 2003·Gastroenterology·Chinyu G Su, Gary R Lichtenstein
Jun 30, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen B HanauerPaul Rutgeerts
Aug 26, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elana A MaserGordon R Greenberg
Dec 13, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gauree GuptaJames D Lewis
Jun 6, 2007·Current Treatment Options in Gastroenterology·Mark T Osterman, Gary R Lichtenstein
Jun 29, 2011·Gastroenterology·Laurent Peyrin-BirouletUNKNOWN Cesame Study Group
Nov 8, 2011·JAMA : the Journal of the American Medical Association·Carlos G GrijalvaJeffrey R Curtis
Mar 6, 2013·Arthritis and Rheumatism·Timothy BeukelmanUNKNOWN SABER Collaboration
Mar 22, 2013·American Journal of Epidemiology·Björn PasternakAnders Hviid

❮ Previous
Next ❯

Citations

Aug 10, 2015·Clinical Pharmacokinetics·Mehmet CoskunOle Haagen Nielsen
Jan 23, 2016·Expert Opinion on Drug Safety·Konstantinos PapamichaelLaurent Peyrin-Biroulet
Jun 23, 2016·Expert Opinion on Biological Therapy·Lieven PouillonLaurent Peyrin-Biroulet
May 8, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ryan W StidhamPeter D R Higgins
Jul 13, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Haggai Bar-YosephYehuda Chowers
Mar 10, 2018·Inflammatory Bowel Diseases·Martine A AardoomLissy de Ridder
May 24, 2017·World Journal of Gastrointestinal Pharmacology and Therapeutics·Keith S SultanSundas Khan
Jun 6, 2018·Digestion·Marcel Vetter, Markus F Neurath
Apr 27, 2019·Expert Opinion on Drug Safety·Aviv PudipeddiRupert Wl Leong
May 23, 2019·Alimentary Pharmacology & Therapeutics·Antoine MeyerAlain Weill
Aug 10, 2019·Journal of Gastroenterology and Hepatology·Taku KobayashiTadakazu Hisamatsu
Jul 13, 2017·Clinical Pharmacology and Therapeutics·Pieter HindryckxSilvio Danese
May 5, 2017·Alimentary Pharmacology & Therapeutics·A N AnanthakrishnanR S Sandler
Jun 13, 2020·United European Gastroenterology Journal·Andrew WisniewskiUNKNOWN the Saint-Antoine IBD network
Feb 4, 2016·Current Opinion in Gastroenterology·Laura E TargownikAmit S Dhillon
Sep 30, 2018·Current Gastroenterology Reports·Christopher M Johnson, Themistocles Dassopoulos
Aug 26, 2017·Frontline Gastroenterology·Anthony O'ConnorAlexander C Ford
Sep 7, 2019·Expert Review of Gastroenterology & Hepatology·Patrizia AlvisiClaudio Romano
Apr 23, 2021·Journal of Gastroenterology·Hiroshi NakaseKazuhiko Koike
Sep 4, 2020·Journal of Gastroenterology and Hepatology·Raphael P LuberMark G Ward

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.